Key result
Bias from blood sampling and analytical performance significantly influences cholesterol screening outcomes, requiring at least three blood specimens to estimate an individual's homeostatic set point.
Why the study?
How do analytical and preanalytical variations affect cholesterol measurements in screening programs?
How do analytical and preanalytical variations affect cholesterol measurements in screening programs?
Accurate estimation of an individual's baseline cholesterol in screening programs requires at least three blood samples to overcome preanalytical and analytical variations.
Single-sample cholesterol screening risks misclassification from bias; leaves open validation of multi-sample protocols before clinical adoption.
In screening programmes one should distinguish between the traditional bimodal distributions of results and a unimodal distribution as the basis for interpretation. A model for evaluation of the effects of biological within-subject and preanalytical variation as well as analytical variation is described. It is concluded that bias from blood sampling and analytical performance influences the outcome of screening programs significantly. At least three blood specimens are needed for estimating the homeostatic set point of cholesterol in individuals.
No takes yet. Share an insight, caveat, or question.
Petersen et al. (1990) studied Cholesterol screening. Model for evaluation of analytical and preanalytical variations was evaluated on Effects of biological within-subject, preanalytical, and analytical variation on cholesterol measurements. Bias from blood sampling and analytical performance significantly influences cholesterol screening outcomes, requiring at least three blood specimens to estimate an individual's homeostatic set point.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: